Skip to main content
. 2017 Feb 1;7:41723. doi: 10.1038/srep41723

Table 3. Serum proteins differentially expressed 5 weeks post-surgery by 2-DE analysis in the group of CCI-saline and identified by Q-ToF LC/MS.

Entry name(a) Protein full name Acc. number(b) Gene name MW (Da) Score(c) Peptide match/sig. match(d) Seq/ sig. seq(e) Seq. cov(f). emPAI(g) Fold change(h) Fold change(i)
VDBP Vitamin D-binding protein P04276 Gc 55106 642 52/37 14/10 30% 1.01 +8.5 0.96
A1M Alpha-1-macroglobulin Q63041 A1m 168388 4989 299/218 17/15 13% 0.62 +6.1 0.84
APOA1 Apolipoprotein A-I P04639 Apoa1 30100 1083 90/69 23/20 59% 14.29 +22.6 +1.92
PTGDS Prostaglandin-D H2-isomerase P22057 Ptgds 21301 709 42/36 6/5 31% 3.71 +7.6 +1.45
TTR Transthyretin P02767 Ttr 15824 750 45/32 11/8 59% 7.42 +20.4(j) no detect(k).
APOE Apolipoprotein E P02650 Apoe 35788 4187 230/182 27/20 64% 14.63 +3.3 +2.8

(a)Protein entry name (all with extension_RAT) from UniProtKB database, conforming to Fig. 4.

(b)Primary accession number from UniProtKB database.

(c)The highest scores by MASCOT search engine.

(d)Total number of matched peptides and the significant matches.

(e)Total number of sequences and the number of significant sequences.

(f)Percentage of amino acids sequenced for the detected protein.

(g)Exponentially modified protein abundance index.

(h)Protein spot intensity change in CCI-saline vs sham-operated saline.

(i)Protein spot intensity change in CCI-indomethacin vs sham-operated saline.

(j)Fold change was calculated towards CCI-indomethacin since sham-operated rats had no detectable spot.

(k)Fold change was not calculated since sham-operated rats had no detectable spot.